Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Correspondence:
View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peskind, E. R.
Right arrow Articles by Raskind, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peskind, E. R.
Right arrow Articles by Raskind, M. A.
Neurology 2001;56:1094-1098
© 2001 American Academy of Neurology


Articles

Increased CSF cortisol in AD is a function of APOE genotype

E. R. Peskind, MD;, C. W. Wilkinson, PhD;, E. C. Petrie, MD;, G. D. Schellenberg, PhD; and M. A. Raskind, MD

From the Mental Illness Research, Education, and Clinical Center (MIRECC) (Drs. Peskind and Raskind) and Geriatric Research, Education, and Clinical Center (GRECC) (Drs. Wilkinson and Schellenberg), VA Puget Sound Health Care System; and Departments of Psychiatry and Behavioral Sciences (Drs. Peskind, Wilkinson, Petrie, and Raskind) and Medicine (Dr. Schellenberg), University of Washington School of Medicine, Seattle.

Address correspondence and reprint requests to Dr. E.R. Peskind, Mental Illness Research, Education, and Clinical Center (116MIRECC), VA Puget Sound Health Care System, 1660 S. Columbian Way, Seattle, WA 98108; e-mail: peskind.elaine{at}seattle.va.gov

BACKGROUND: Increased hypothalamic–pituitary–adrenal (HPA) axis activity manifested by elevated cortisol levels is observed in AD and may contribute to AD by lowering the threshold for neuronal degeneration. Presence of the APOE-{epsilon}4 allele increases risk for AD. Increased cortisol concentrations in apoE-deficient mice suggest that APOE genotype may influence cortisol concentrations in AD.

METHODS: The authors measured cortisol levels in CSF and determined APOE genotypes for 64 subjects with AD and 34 nondemented older control subjects.

RESULTS: CSF cortisol was significantly higher in AD than in control subjects. CSF cortisol concentrations differed with respect to APOE genotype in both subjects with AD ({epsilon}4/{epsilon}4 > {epsilon}3/4{epsilon} > {epsilon}3/{epsilon}3) and normal older control subjects ({epsilon}3/{epsilon}4 > {epsilon}3/{epsilon}3 > {epsilon}2/{epsilon}3). Comparison of CSF cortisol concentrations within the {epsilon}3/{epsilon}4 and {epsilon}3/{epsilon}3 genotypes revealed no differences between AD and control subject groups.

CONCLUSIONS: Higher CSF cortisol concentrations were associated with increased frequency of the APOE-{epsilon}4 allele and decreased frequency of the APOE-{epsilon}2 allele in AD subjects relative to control subjects. This effect of APOE genotype on HPA axis activity may be related to the increased risk for AD in persons carrying the APOE-{epsilon}4 allele and decreased risk for AD in persons carrying the APOE-{epsilon}2 allele.




This article has been cited by other articles:


Home page
AJGPHome page
Y.-C. Yen, G. W. Rebok, J. J. Gallo, M.-J. Yang, F.-W. Lung, and C.-H. Shih
ApoE4 Allele Is Associated With Late-Life Depression: A Population-Based Study
Am J Geriatr Psychiatry, October 1, 2007; 15(10): 858 - 868.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. S. Wilson, J. A. Schneider, P. A. Boyle, S. E. Arnold, Y. Tang, and D. A. Bennett
Chronic distress and incidence of mild cognitive impairment
Neurology, June 12, 2007; 68(24): 2085 - 2092.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. N. Green, L. M. Billings, B. Roozendaal, J. L. McGaugh, and F. M. LaFerla
Glucocorticoids Increase Amyloid-beta and Tau Pathology in a Mouse Model of Alzheimer's Disease.
J. Neurosci., August 30, 2006; 26(35): 9047 - 9056.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
T. Freeman, V. Roca, F. Guggenheim, T. Kimbrell, and W.S.T. Griffin
Neuropsychiatric Associations of Apolipoprotein E Alleles in Subjects With Combat-Related Posttraumatic Stress Disorder
J Neuropsychiatry Clin Neurosci, November 1, 2005; 17(4): 541 - 543.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
D. G. Baker, N. N. Ekhator, J. W. Kasckow, B. Dashevsky, P. S. Horn, L. Bednarik, and T. D. Geracioti Jr.
Higher Levels of Basal Serial CSF Cortisol in Combat Veterans With Posttraumatic Stress Disorder
Am J Psychiatry, May 1, 2005; 162(5): 992 - 994.
[Abstract] [Full Text] [PDF]


Home page
FocusHome page
A. F. Schatzberg
Recent Studies of the Biology and Treatment of Depression
Focus, January 1, 2005; 3(1): 14 - 24.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
M. Grundman
Weight Loss in the Elderly May Be a Sign of Impending Dementia
Arch Neurol, January 1, 2005; 62(1): 20 - 22.
[Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
R. J. Caselli, E. M. Reiman, J. G. Hentz, D. Osborne, and G. E. Alexander
A Distinctive Interaction Between Chronic Anxiety and Problem Solving in Asymptomatic APOE e4 Homozygotes
J Neuropsychiatry Clin Neurosci, August 1, 2004; 16(3): 320 - 329.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
D. J.-F. de Quervain, R. Poirier, M. A. Wollmer, L. M.E. Grimaldi, M. Tsolaki, J. R. Streffer, C. Hock, R. M. Nitsch, M. H. Mohajeri, and A. Papassotiropoulos
Glucocorticoid-related genetic susceptibility for Alzheimer's disease
Hum. Mol. Genet., January 1, 2004; 13(1): 47 - 52.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Raber, G. Bongers, A. LeFevour, M. Buttini, and L. Mucke
Androgens Protect against Apolipoprotein E4-Induced Cognitive Deficits
J. Neurosci., June 15, 2002; 22(12): 5204 - 5209.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. O. Sass, P. Heinz-Erian, W. Hogler, C. W. Wilkinson, and E. R. Peskind
Increased CSF cortisol in AD is a function of APOE genotype
Neurology, October 23, 2001; 57(8): 1522 - 1523.
[Full Text] [PDF]

Correspondence:

Read all Correspondence

Increased CSF cortisol in AD is a function of APOE genotype
Jorn Oliver Sass, et al.
Neurology Online, 10 Jun 2001 [Full text]
Reply to Sass et al
Charles W Wilkinson, et al.
Neurology Online, 10 Jun 2001 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by AAN Enterprises, Inc.